Coherus Oncology (CHRS) Acquisitions (2014)
Coherus Oncology (CHRS) posted Acquisitions of $2.3 million for Q1 2014.
Coherus Oncology (CHRS) Acquisitions (2014) Analysis & Trends
Coherus Oncology has reported Acquisitions for 1 years, with the latest figure at $2.3 million in Q1 2014.
- Quarterly Acquisitions changed N/A year-over-year to $2.3 million in Q1 2014, while the trailing twelve-month figure through Dec 2014 was $2.3 million (changed N/A YoY) and the FY2023 annual result came in at $7.0 million, changed N/A from the prior year.
- Acquisitions held at $2.3 million in Q1 2014 per CHRS's latest filing.
- Over five years, Acquisitions peaked at $2.3 million in Q1 2014 and troughed at $2.3 million in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Coherus Oncology | 203.82 Mn | 98.51 Mn | 10.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 2.33 Mn |